Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain?
Epiphora, Dacryostenosis, Dacryocystitis
About this trial
This is an interventional treatment trial for Epiphora focused on measuring Nasolacrimal duct obstruction, Probe and irrigation
Eligibility Criteria
Inclusion Criteria: Participants of any sex aged 18 years or older Signs and symptoms of epiphora which necessitate performance of a diagnostic probing and irrigation of the bilateral lower eyelid lacrimal drainage system at Louisiana State University Health Sciences Center or any of the listed physician offices who present with a complaint of epiphora from either eye Exclusion Criteria: A known allergy to topical proparacaine hydrochloride Known pre-existing scarring, surgery, radiation to the nasolacrimal system Presence of blockage and or reflux on probing and irrigation of either side Cognitive Impairment
Sites / Locations
- Louisiana State University Health Sciences CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Participants with no obstruction of the lacrimal system
Participants with obstruction of the lacrimal system
Patients will have received a drop of Proparacaine Hydrocholoride 0.5% ophthalmic solution in one eye and a drop of BSS in the other eye prior to probing and irrigation.
Participants who have a blockage in their tear drainage system on probing and irrigation. Participants will have received a drop of Proparacaine Hydrocholoride 0.5% ophthalmic solution in one eye and a drop of BSS in the other eye prior to probing and irrigation.